Oral administration of docosahexaenoic acid activates the GDNF-MAPK-CERB pathway in hippocampus of natural aged rat

References

• Acsády L, Pascual M, Rocamora N, et al. (2000). Nerve growth factor but not neurotrophin-3 is synthesized by hippocampal GABAergic neurons that project to the medial septum. J Neurosci 98:23–31
   Google Scholar
• Airaksinen MS, Saarma M. (2002). The GDNF family: Signaling, biological functions and therapeutic value. Nat Rev Neurosci 3:383–94
   PubMed Web of Science ®Google Scholar
• Bligh EG, Dyer W. (1959). A rapid method of total lipid extraction and purification. Can J Biochem Physiol 37:911–17
   PubMedGoogle Scholar
• Catalan J, Moriguchi T, Slotnick B, et al. (2002). Cognitive deficits in docosahexaenoic acid-deficient rats. Behav Neurosci 116:1022–31
   PubMed Web of Science ®Google Scholar
• Chao CC, Lee EH. (1999). Neuroprotective mechanism of glial cell line-derived neurotrophic factor on dopamine neurons: Role of antioxidation. Neuropharmacology 38:913–16
   PubMed Web of Science ®Google Scholar
• Ciccarelli R, Ballerini P, Sabatino G, et al. (2001). Involvement of astrocytes in purine-mediated reparative processes in the brain. Int J Dev Neurosci 19:395–414
   PubMed Web of Science ®Google Scholar
• Creedon DJ, Tansey MG, Baloh RH, et al. (1997). Neurturin shares receptors and signal transduction pathways with glial cell line-derived neurotrophic factor in sympathetic neurons. Proc Natl Acad Sci USA 94:7018–23
   PubMed Web of Science ®Google Scholar
• Fischer W, Wictorin K, Björklund A, et al. (1987). Amelioration of cholinergic neuron atrophy and spatial memory impairment in aged rats by nerve growth factor. Nature 329:65–8
   PubMed Web of Science ®Google Scholar
• Gash DM, Zhang Z, Ovadia A, et al. (1996). Functional recovery in GDNF treated Parkinsonian monkeys. Nature 380:252–5
   PubMed Web of Science ®Google Scholar
• Gong L, Wyatt RJ, Baker I, Masserano JMB. (1999). Brain-derived and glial cell line-derived neurotrophic factors protect a catecholaminergic cell line from dopamine-induced cell death. Neurosci Lett 263:153–6
   PubMed Web of Science ®Google Scholar
• Grondin R, Cass WA, Zhang Z, et al. (2003). Glial cell line-derived neurotrophic factor increases stimulus-evoked dopamine release and motor speed in aged rhesus monkeys. J Neurosci 23:1974–80
   PubMed Web of Science ®Google Scholar
• Hebert MA, Gerhardt GA. (1997). Behavioral and neurochemical effects of intranigral administration of glial cell line-derived neurotrophic factor on aged Fischer 344 rats. J Pharmacol Exp Ther 282:760–8
   PubMedGoogle Scholar
• Hossain MS, Hashimoto M, Gamoh S, Masumura S. (1999). Antioxidative effects of docosahexaenoic acid in the cerebrum versus cerebellum and brainstem of aged hypercholesterolemic rats. J Neurochem 72:1133–8
   PubMed Web of Science ®Google Scholar
• Innis SM. (2000). The role of dietary n-6 and n-3 fatty acids in the developing brain. Dev Neurosci 22:474–80
   PubMed Web of Science ®Google Scholar
• Jiang LH, Shi Y, Wang LS, Yang ZH. (2009a). The influence of orally administered docosahexaenoic acid on cognitive ability in aged mice. J Nutr Biochem 20:735–41
   PubMedGoogle Scholar
• Jiang LH, Yan S, Long Y, Yang ZR. (2009b). The influence of orally administered docosahexaenoic acid on monoamine neurotransmitter, nerve growth factor and brain-derived neurotrophic factor in aged mice. Pharm Biol 47:584–91
   Web of Science ®Google Scholar
• Jiang LH, Liang QY, Shi Y. (2012). Pure docosahexaenoic acid can improve depression behaviors and affect HPA axis in mice. Eur Rev Med Pharmacol Sci 16:1765–73
   PubMedGoogle Scholar
• Jing S, Wen D, Yu Y, et al. (1996). GDNF-induced activation of the ret protein tyrosine kinase is mediated by GDNFR-alpha, a novel receptor for GDNF. Cell 85:1113–24
   PubMed Web of Science ®Google Scholar
• Kawashima A, Harada T, Kami H, et al. (2010). Effects of eicosapentaenoic acid on synaptic plasticity, fatty acid profile and phosphoinositide 3-kinase signaling in rat hippocampus and differentiated PC12 cells. J Nutr Biochem 21:268–77
   PubMed Web of Science ®Google Scholar
• Kiray M, Uysal N, Sönmez A, et al. (2004). Positive effects of deprenyl and estradiol on spatial memory and oxidant stress in aged female rat brains. Neurosci Lett 354:225–8
   PubMedGoogle Scholar
• Kirik D, Georgievska B, Björklund A. (2004). Localized striatal delivery of GDNF as a treatment for Parkinson disease. Nat Neurosci 7:105–10
   PubMed Web of Science ®Google Scholar
• Lim SY, Suzuki H. (2002). Dose-response effect of docosahexaenoic acid ethyl ester on maze behavior and brain fatty acid composition in adult mice. Int J Vitam Nutr Res 72:77–84
   PubMed Web of Science ®Google Scholar
• Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. (1951). Protein measurement with the Folin phenol reagent. J Biol Chem 193:265–75
   PubMed Web of Science ®Google Scholar
• McGahon BM, Martin DS, Horrobin DF, Lynch MA. (1999). Age-related changes in synaptic function: Analysis of the effect of dietary supplementation with omega-3 fatty acids. J Neurosci 94:305–14
   Google Scholar
• Mena MA, Casarejos MJ, Carazo A, et al. (1997). Glia protect fetal midbrain dopamine neurons in culture from L-DOPA toxicity through multiple mechanisms. J Neural Transm 104:317–28
   PubMed Web of Science ®Google Scholar
• Montine TJ, Neely MD, Quinn JF, et al. (2002). Lipid peroxidation in aging brain and Alzheimer’s disease. J Free Radic Biol Med 33:620–6
   Google Scholar
• Mori TA, Woodman RJ, Burke V, et al. (2003). Effect of eicosapentaenoic acid and docosahexaenoic acid on oxidative stress and inflammatory markers in treated-hypertensive type 2 diabetic subjects. Free Radic Biol Med 35:772–81
   PubMed Web of Science ®Google Scholar
• Nourooz-Zadeh J, Liu EH, Yhlen B, et al. (1999). F4-isoprostanes as specific marker of docosahexaenoic acid peroxidation in Alzheimer’s disease. J Neurochem 72:734–40
   PubMed Web of Science ®Google Scholar
• Oyanagui Y. (1984). Reevaluation of assay methods and establishment of kit for superoxide dismutase activity. Anal Biochem 142:290–6
   PubMed Web of Science ®Google Scholar
• Peng S, Zhang Y, Zhang JN, et al. (2010). ERK in learning and memory: A review of recent research. Int J Mol Sci 11:222–32
   PubMed Web of Science ®Google Scholar
• Rangasamy SB, Soderstrom K, Bakay RA, Kordower JH. (2010). Neurotrophic factor therapy for Parkinson’s disease. Progr Brain Res 184:237–64
   PubMed Web of Science ®Google Scholar
• Scott Bitner R. (2012). Cyclic AMP response element-binding protein (CREB) phosphorylation: A mechanistic marker in the development of memory enhancing Alzheimer’s disease therapeutics. Biochem Pharmaco 83:705–14
   PubMedGoogle Scholar
• Song JH, Miyazawa T. (2001). Enhanced level of n-3 fatty acid in membrane phospholipids induces lipid peroxidation in rats fed dietary docosahexaenoic acid oil. Atherosclerosis 155:9–18
   PubMedGoogle Scholar
• Songur A, Sarsilmaz M, Sogut S, et al. (2004). Hypothalamic superoxide dismutase, xanthine oxidase, nitric oxide, and malondialdehyde in rats fed with fish ω-3 fatty acids. Progr Neuropsychopharmacol Biol Psychiatry 28:693–8
   PubMed Web of Science ®Google Scholar
• Tabner BJ, Turnbull S, El-Agnaf O, Allsop D. (2001). Production of reactive oxygen species from aggregating proteins implicated in Alzheimer's disease, Parkinson's disease and other neurodegenerative diseases. Curr Top Med Chem 6:507–17
   Google Scholar
• Tanriover G, Seval-Celik Y, Ozsoy O, et al. (2010). The effects of docosahexaenoic acid on glial derived neurotrophic factor and neurturin in bilateral rat model of Parkinson’s disease. Folia Histochem Cytobiol 48:434–41
   PubMed Web of Science ®Google Scholar
• Tansey MG, Baloh RH, Milbrandt J, Johnson EM Jr. (2000). GFRa-mediated localization of RET to lipid rafts is required for effective downstream signaling, differentiation and neuronal survival. Neuron 25:611–23
   PubMed Web of Science ®Google Scholar
• Treanor JJ, Goodman L, de Sauvage F, et al. (1996). Characterization of a multicomponent receptor for GDNF. Nature 382:80–3
   PubMed Web of Science ®Google Scholar
• Wu A, Ying Z, Gomez-Pinilla F. (2004). Dietary omega-3 fatty acids normalize BDNF levels, reduce oxidative damage, and counteract learning disability after traumatic brain injury in rats. J Neurotrauma 21:1457–67
   PubMed Web of Science ®Google Scholar